|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.9 TWD | -0.23% |
|
+1.54% | -11.36% |
Maxigen Biotech Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 143.03 million compared to TWD 123.26 million a year ago. Net income was TWD 44.45 million compared to TWD 20.55 million a year ago.
Basic earnings per share from continuing operations was TWD 0.4952 compared to TWD 0.2286 a year ago. Diluted earnings per share from continuing operations was TWD 0.4952 compared to TWD 0.2286 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.36% | 118M | |
| -2.16% | 254B | |
| 0.00% | 18.26B | |
| +0.38% | 11.16B | |
| -6.60% | 10.38B | |
| +16.34% | 7.63B | |
| +10.15% | 5.97B | |
| +1.12% | 4.65B | |
| -17.29% | 3.81B | |
| -5.56% | 3.54B |
MAXIGEN BIOTECH INC. 
